Home / Guides / By state / Semaglutide in Virginia

The pen first, then the pill.

Best semaglutide providers in Virginia, 2026

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated

NexLife publishes this guide and is one of the programs in it. Every program, ours included, faces the same tests, and every price links to its source.

Virginia Medicaid puts injectable Wegovy first among weight-loss GLP-1s; compounded semaglutide online runs $119 to $299 a month in our price index (checked November 1, 2026). Through NexLife, compounded semaglutide is $119 a month on the 12-month plan, or $139 month to month, at every dose.

$119/mo on 12 months, every dosePrice Match Guarantee†

  • Medicaid names injectable Wegovy its selected weight-loss GLP-1
  • Wegovy pills: a reason not to inject, or two failed injectables
  • Sterile compounders must tell Virginia’s Board they deliver here
NexLifeEvery dose, one price
Illustration of a compounded semaglutide vial

$119/mo on a 12-month plan, all-inclusive, same price at every dose

Or $139/mo month to month

Check my eligibility

About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication

See all 4 plans and what a year costs
Compounded semaglutide, all in, the same price at every dose
PlanPer month12 months at this rate
12-month Lowest monthly price$119$1,428
6-month$125$1,500
3-month$132$1,584
Month to month$139$1,668

Month to month costs $240 more over 12 months than the 12-month plan. Plans renew until you cancel. Longer plans bill the way you choose at checkout.

Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works

4.8 out of 5 on Trustpilot, 407 reviewsLegitScript-certified

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.

  • Licensed U.S. providers
  • LegitScript certified
  • Free expedited shipping
  • HSA, FSA, Affirm, Klarna, Afterpay
  • 24/7 support, real people
  • Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)

At a glance

Semaglutide in Virginia: the short answers

Semaglutide in Virginia at a glance, checked November 2, 2026
QuestionAnswer
Virginia MedicaidCovered for weight loss only with criteria
The state employee planCommonwealth of Virginia State Health Benefits Program: covered for weight loss only with criteria
Who can prescribe itA provider licensed in Virginia
Compounded semaglutide, without insurance$119 to $299 a month online in our price index, all in (median $199, checked November 1, 2026)
At NexLife$119 a month on the 12-month plan, or $139 month to month, the same at every dose
Summer heat, 202693 of 122 days at 86°F or more in Danville and Southside
  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Free expedited shipping

Key takeaways

  • Virginia Medicaid covers Wegovy for weight loss only with criteria (checked November 2, 2026).
  • Virginia’s state employee plan covers GLP-1 drugs for weight loss only with criteria.
  • Your prescriber needs a Virginia license to treat you there.
  • Compounded semaglutide costs $119 to $299 a month online in our price index, all in (median $199, checked November 1, 2026).
  • Summer 2026: Danville and Southside hit 86°F or more on 93 of 122 days. Bring deliveries in fast.
  • At NexLife: $119 a month on the 12-month plan, the same at every dose.

Picks

Which semaglutide provider is best for you?

Online semaglutide programs, by what each does best and its catch. Prices are each program’s online price in our price index (checked November 1, 2026); check that a program serves Virginia before you pay.

Which online semaglutide program fits you in Virginia
Best forProgramPriceThe catch
Publisher of this guideNexLife$119 a month on the 12-month plan; $139 month to month; the same at every dose, no membership feeCancel by email, effective 30 days after NexLife receives it
Lowest month-to-month price in our indexPreventiveMD$119 a month at every dose, no membership fee (checked November 2, 2026)Its prepaid 3- to 12-month rates aren’t in our index
Lowest 12-month price in our indexOndra Health$96 a month, $1,149 paid upfrontUpfront for 12 months, through some of its pharmacies
Obesity-medicine doctorsMochi Health$139 at the lowest dose, its $79 membership includedThe price rises with your dose
FDA-approved WegovyNovoCare PharmacyPill $149 to $299 a month; pen $349 after two $199 fills ($399 at 7.2 mg)Medication only, before any prescriber’s fee

Where you live

What changes depending on where you live in Virginia?

Not your price: NexLife’s price is the same anywhere in Virginia, and care is online. What changes is the heat at your door. In summer 2026, Danville reached 86°F or more, the most Wegovy’s label allows outside the fridge, on 93 of 122 days, Roanoke on 70 and Harrisonburg area on 46.

RestonNorfolkRoanokeForestShenandoah ValleyDanvilleSouthwest Virginia
Statewide

Pick your region on the map

Tap a city to see its region’s summer heat and what to plan for. Every region is in the table below too.

  • 9weather stations counted
  • 46–93days at 86°F or more
  • 103°Fhottest, Charlottesville

Wherever you live in Virginia, care is online and your medicine ships to your door.

Virginia regions and their summer 2026 heat at the NOAA weather station that represents each one (daily highs, June 1 to Sept. 30; our count from ACIS)
RegionMain citiesDays at 86°F or more
Northern VirginiaArlington, Alexandria, Fairfax, Reston, Leesburg, Manassas70 of 122 · hottest 99°F
Hampton RoadsVirginia Beach, Norfolk, Chesapeake, Newport News, Hampton, Portsmouth68 of 122 · hottest 100°F
Richmond areaRichmond, Glen Allen, Midlothian, Mechanicsville, Petersburg83 of 122 · hottest 100°F
Roanoke and the New River ValleyRoanoke, Salem, Vinton, Blacksburg, Christiansburg, Radford70 of 122 · hottest 100°F
Lynchburg areaLynchburg, Forest, Bedford, Amherst72 of 122 · hottest 101°F
Shenandoah ValleyHarrisonburg, Staunton, Waynesboro, Bridgewater46 of 122 · hottest 96°F
Charlottesville areaCharlottesville, Crozet, Ruckersville, Scottsville69 of 121 · hottest 103°F
Danville and SouthsideDanville, Martinsville, South Boston, Chatham93 of 122 · hottest 103°F
Southwest VirginiaBristol, Abingdon, Wise, Norton, Marion79 of 122 · hottest 98°F

Heat

How do you keep semaglutide cold in a Virginia summer?

A Wegovy single-dose pen can be kept at 46°F to 86°F for up to 28 days before the cap comes off; the FlexTouch pen stays in the fridge until first use. Compounded vials follow their own pharmacy label, which is often stricter. In summer 2026, Danville and Southside reached 86°F or more on 93 of 122 days.

  1. Danville93 of 122
  2. Richmond83 of 122
  3. Bristol (Tri-Cities)79 of 122
  4. Lynchburg72 of 122
  5. Roanoke70 of 122
  6. Dulles70 of 122
  7. Charlottesville69 of 121
  8. Norfolk68 of 122
  9. Harrisonburg area46 of 122
Days with a high of 86°F or more, June 1 to Sept. 30, 2026, at 9 NOAA weather stations in and near Virginia (ACIS daily data; our count). Days without data: Charlottesville 1.

From NOAA’s daily maximum temperatures (ACIS), June 1 to September 30, 2026; our count. The label.

What to do. Plan deliveries for when you’re home and bring the box inside right away. Orders through NexLife ship with cold packs. A box that shows up warm shouldn’t be used: call or text (949) 818-8000 and we’ll take it from there.

In a disaster. Virginia's refill law sets no day limit. If your prescriber can't be reached and your health would be in imminent danger without the drug, a pharmacist may refill it without approval, even using only your container's label. The pharmacist must tell you and your prescriber. Code of Virginia (Virginia General Assembly, LIS)

Coverage

Does insurance cover semaglutide in Virginia?

Each kind of plan in Virginia: what it covers for weight loss, with its source.

Who pays for semaglutide in Virginia, by plan, checked November 2, 2026
Your planFor weight lossWhat to know
Virginia MedicaidCovered for weight loss only with criteriaYes, with prior approval. Virginia Medicaid covers Wegovy injections from age 12 if BMI is over 40, or over 37 with abnormal cholesterol, high blood pressure or type 2 diabetes, and a non-GLP-1 drug failed. Tablets also need a reason to avoid injections or two failed injectables. Non-preferred since Aug. 1, 2024. (source)
State employees
Commonwealth of Virginia State Health Benefits Program
Covered for weight loss only with criteriaWeight-loss GLP-1s such as Wegovy need prior authorization and, since July 1, 2026, a BMI of 35 or higher for new approvals. COVA Care added a $150/$300 pharmacy deductible for Tier 2-4 drugs. Check Wegovy on the new drug list. (source)
The Local Choice (Key Advantage plans)
local government and school division employees
Not covered for weight lossThe Local Choice serves Virginia local governments and school systems. Its Key Advantage handbook, effective July 1, 2026, lists drugs for weight loss as not covered. Bariatric surgery may be covered after a 6-month weight program. (source)
UVA Health Plan (Aetna)
University of Virginia and UVA Health employees
Covered for weight loss only with criteriaUVA's employee health plan requires members taking GLP-1s for weight loss to join its weight management program. Zepbound and Foundayo became preferred brands on Oct. 1, 2026; check Wegovy's status. (source)
Job-based and marketplace plansDepends on the planVirginia's obesity law makes large-group insurers offer coverage for treating morbid obesity by gastric bypass or other NIH-recognized methods. Ask HR whether your plan covers Zepbound or Wegovy for weight, what prior authorization requires, and whether the plan is insured or self-funded. (source)
Medicare
Part D
$50 a month, if you qualifyMedicare’s GLP-1 Bridge covers Wegovy (pen or pill), Foundayo and the Zepbound KwikPen for $50 a month, July 1, 2026 to December 31, 2027, for Part D enrollees who qualify, with prior authorization. (source)
TRICAREPrime and Select: in certain circumstancesTRICARE Prime and Select still cover weight-loss medications in certain circumstances. TRICARE For Life has been excluded since August 31, 2025. TRICARE
No insuranceYou pay cashCompounded semaglutide costs $119 to $299 a month online in our price index, all in (median $199, checked November 1, 2026). At NexLife, it’s $119 a month on the 12-month plan, or $139 month to month, the same at every dose.

If your plan says no. If a state-regulated plan says a drug isn't medically necessary, request external review from the State Corporation Commission within 120 days of the final denial. The insurer pays the reviewer. Decisions come within 45 days (72 hours if urgent). Plan exclusions can't be overturned. Medicare, Medicaid and self-funded plans that don't opt in are excluded. (source)

In their words

What do Virginia Medicaid and Virginia’s boards say about semaglutide?

Three lines, word for word: from Medicaid’s weight-loss form, the Board of Medicine and the Board of Pharmacy.

On Virginia Medicaid, the weight-loss form sets the BMI bar for injectable Wegovy:

“BMI > 40 kg/m2 if no applicable risk factors; OR BMI > 37 kg/m2 with one or more of the following risk factors: dyslipidemia, hypertension, or type 2 diabetes”

Virginia Department of Medical Assistance Services (DMAS form, copy hosted by UnitedHealthcare Community Plan of Virginia), Commonwealth of Virginia DMAS Service Authorization (SA) Form: Weight-Loss Management

This is why the prescriber check asks for a Virginia license, even for care that starts online:

“The establishment of a new practitioner-patient relationship requires a Virginia license and must comport with the requirements for telemedicine found in § 54.1-3303 of the Code of Virginia.”

Virginia Board of Medicine, Guidance Document 85-12: Telemedicine

For compounded semaglutide injections, the Board of Pharmacy is specific about who may ship into Virginia:

“only nonresident pharmacies registered by the Virginia Board of Pharmacy may ship compounded sterile products into Virginia.”

Virginia Board of Pharmacy, Guidance Document 110-36: Compliance with USP Standards for Compounding

State rules

What does Virginia law require before you get semaglutide online?

Each rule, in plain words, with the law or board that sets it.

Virginia rules for semaglutide online, checked November 2, 2026
RuleWhat it means for youSource
Getting care onlineYour prescriber needs an active Virginia license. Virginia law requires your medical history, information on the drug's benefits and risks, an appropriate exam, a diagnosis, care that meets the in-person standard, and follow-up when needed. Records must be provided on request.Va. Code § 54.1-3303(B); Virginia Board of Medicine Guidance Document 85-12 (Telemedicine, effective Aug. 19, 2021) (source)
Your prescriber’s licenseA prescriber must hold a Virginia license to treat you while you're in Virginia, including online; the Board of Medicine says care happens where the patient is. Virginia's official list of interstate compacts doesn't include the Interstate Medical Licensure Compact. Look it up.(source)
Nurse practitioners and PAsNurse practitioners with three years' full-time experience and a Board-approved attestation may practice without a physician agreement; others need one. PAs prescribe under a practice agreement. A 2026 law freeing experienced PAs from that waits on Board rules.Va. Code §§ 54.1-2957(C) and (I), 54.1-2952.1; Acts 2026, c. 418 (HB 746), enactment clause 3 (source)
The pharmacyAn out-of-state pharmacy must register with Virginia's Board of Pharmacy as a nonresident pharmacy and name a Virginia-licensed pharmacist-in-charge. It must send an inspection report showing USP compounding compliance, no older than six months for new registrations or two years for renewals. Sterile compounders must also tell the Board before shipping into Virginia. Look it up.Va. Code §§ 54.1-3434.1(A) and 54.1-3410.2(K); Board of Pharmacy Guidance Documents 110-36 and 110-38 (source)
Compounding, October 8, 2026Virginia's health boards issued med spa guidance naming GLP-1s. It says compounded drugs aren't FDA-approved, compounding must meet USP standards, and each patient needs a prescriber's evaluation and patient-specific order, not standing orders.Virginia Department of Health Professions Guidance Document 76-1 (source)
Compounding, June 19, 2025Nonresident pharmacies that compound sterile drugs, such as injections, must submit an operational inspection report showing USP sterile compliance to register or renew with Virginia. An opening inspection report isn't enough.Virginia Board of Pharmacy Guidance Document 110-38 (source)
Compounding, June 6, 2024Only nonresident pharmacies registered with the Virginia Board of Pharmacy may ship patient-specific compounded sterile products into Virginia. You can check a pharmacy's registration on the state's License Lookup.Virginia Board of Pharmacy Guidance Document 110-36 (source)

5-minute check

How do you check a Virginia pharmacy and prescriber?

  • Ask the program, in writing, which pharmacy fills your prescription, or read the label: it names the pharmacy.
  • Search that pharmacy on Virginia’s pharmacy license lookup. Check that its Virginia license or registration is active.
  • Check the address on the license matches the address on your label.
  • Look up your prescriber on the Virginia license search: a provider treating you in Virginia needs a Virginia license.
  • Check the program on LegitScript’s public list of certified websites.

At NexLife, licensed providers prescribe, and two named partner pharmacies fill prescriptions: Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA). We’re LegitScript-certified.

Step by step

How do you get semaglutide online in Virginia, step by step?

Six steps, from your coverage to a cold box at your door, using Virginia’s own license lookup.

  1. Check your coverage first. Virginia Medicaid covers injectable Wegovy with approval at a BMI over 40, or over 37 with a risk factor, after a failed non-GLP-1 drug. State employee plans need a BMI of 35 or more for new approvals.
  2. Check the prescriber’s license. Look up your prescriber on the Virginia license search. A prescriber must hold a Virginia license to treat you while you’re in Virginia, including online.
  3. Check the pharmacy’s registration. Ask which pharmacy fills your prescription, then search it on Virginia’s pharmacy license lookup. An out-of-state pharmacy must be registered with Virginia’s Board of Pharmacy as a nonresident pharmacy.
  4. Do the online visit. Virginia law requires a medical history, information on the drug’s benefits and risks, an appropriate exam and a diagnosis. A licensed provider decides whether semaglutide is right for you.
  5. Plan the delivery for the heat. In summer 2026, the Richmond area hit 86°F or more on 83 of 122 days, and Northern Virginia on 70. Be home for the delivery, bring the box in right away, and store it as the label says.
  6. If it arrives warm, don’t use it. The FDA recommends not using an injectable GLP-1 that arrives warm. Call or text NexLife at (949) 818-8000, 24/7; with another program, call it or the pharmacy named on your label.
Steps: check your coverage; check the prescriber; check the pharmacy; do the online visit; plan for the heat; arrived warm? Call first1Check your coverage2Check the prescriber3Check the pharmacy4Do the online visit5Plan for the heat6Arrived warm? Call first
The six steps, in order. Your prescriber’s instructions and your pharmacy’s label come first.

Timeline

What changed for semaglutide in Virginia, and when?

Newest first, each with its source.

  1. Virginia's health boards issue med spa guidance naming GLP-1s: compounded drugs aren't FDA-approved, and patients need a prescriber's evaluation. Virginia Department of Health Professions (Boards of Medicine, Nursing and Pharmacy)

  2. Virginia state employee plans start requiring a BMI of 35 or higher for new weight-loss GLP-1 approvals. Virginia Department of Human Resource Management (State Health Benefits Program)

  3. Medicare GLP-1 Bridge starts: $50 a month for eligible Part D enrollees in Virginia, with Medicare approval. Centers for Medicare & Medicaid Services (Medicare.gov)

  4. DMAS revises its weight-loss drug service authorization form: GLP-1s need a BMI over 40, or over 37 with certain conditions. Virginia Department of Medical Assistance Services (DMAS form, copy hosted by UnitedHealthcare Community Plan of Virginia)

  5. Virginia Board of Pharmacy guidance requires operational inspection reports from nonresident pharmacies doing sterile compounding. Virginia Board of Pharmacy

  6. FDA declares the semaglutide injection shortage resolved, limiting routine compounded copies shipped into Virginia. U.S. Food and Drug Administration

  7. Virginia Medicaid moves Wegovy and Saxenda to non-preferred on its drug list; both need service authorization. Virginia Department of Medical Assistance Services

  8. Virginia Board of Pharmacy: only registered nonresident pharmacies may ship compounded sterile products into Virginia. Virginia Board of Pharmacy

Medicaid and Wegovy

When does Virginia Medicaid cover Wegovy?

For weight loss, at a BMI over 40, or over 37 with dyslipidemia, high blood pressure or type 2 diabetes, after a failed non-GLP-1 drug; heart disease and MASH have forms of their own, with lower BMI bars. We read every form on November 1, 2026.

Weight loss: injectable Wegovy first

Virginia’s Medicaid drug list, effective October 1, 2026, files Wegovy, Wegovy HD, Saxenda, Zepbound and Foundayo as non-preferred weight management drugs, so each one needs a service authorization. Its footnote names injectable brand Wegovy, not the high-dose version, as the selected GLP-1 that members try before the others. The weight-loss form, effective October 20, 2026, also asks for nutritional counseling, a physical activity program unless it’s medically ruled out, and height and weight from the last 60 days.

Approvals run 6 months. To renew, the member needs a further 5% drop in body weight, and renewals end once BMI is under 25. A non-GLP-1 drug such as phentermine counts as failed after 3 months without losing 10 pounds (orlistat: 6 months).

Pills: a reason not to inject

The form treats the Wegovy pill as an oral GLP-1 and asks for one more thing before covering it: a medical contraindication to injections, or failed trials of two injectable products. It defines that contraindication as a condition in which an injection raises the risk of a severe, life-threatening allergic or biological reaction. The form lists the pill and Wegovy HD for adults 18 and older, and the Wegovy injection from age 12.

Heart disease: a cardiologist’s form

A separate form, effective May 1, 2026, covers a GLP-1 to lower heart risk in members with obesity or overweight. It applies to adults 45 or older with a past heart attack, stroke or peripheral artery disease and a BMI of 27 or more, with no diabetes diagnosis and no heart attack, stroke, TIA or hospital stay for unstable angina in the last 60 days. A cardiologist or vascular specialist must prescribe it. Coverage starts with 6 months and renews 12 at a time.

MASH: a liver specialist’s form

For MASH (metabolic dysfunction-associated steatohepatitis), the form revised October 16, 2025 covers adults with stage F2 or F3 fibrosis on a liver biopsy, or on a noninvasive test such as FibroScan from the last 6 months. It asks for a BMI of 18.5 or more and an A1C no higher than 9.5%, and a hepatologist, gastroenterologist or other liver specialist must prescribe it or be consulted.

Ozempic and Rybelsus: the diabetes class

Ozempic and Rybelsus, which also contain semaglutide, sit in Medicaid’s diabetes drug class as non-preferred drugs, so each needs a service authorization. The preferred drugs there, Trulicity and Victoza, are for members with a type 2 diabetes diagnosis.

Medicaid’s four routes, side by side

Virginia Medicaid’s routes to Wegovy, from DMAS’s drug list and service authorization forms, read November 1, 2026.
Medicaid routeBMIOther key conditionsApproval
Weight lossinjectable WegovyAbove 40, or above 37 with dyslipidemia, high blood pressure or type 2 diabetesA failed non-GLP-1 drug first; counseling and an activity program6 months; renewal needs a further 5% loss
Weight lossWegovy pillThe sameAlso a medical reason not to inject, or two failed injectables6 months
Heart riskobesity or overweight27 or moreAge 45 or older; past heart attack, stroke or peripheral artery disease; no diabetes; a cardiologist or vascular specialist6 months, then 12
MASHstage F2 or F3 fibrosis18.5 or moreA liver specialist; an A1C of 9.5% or lower6 months, then 12

Swipe the table sideways to see every column.

Virginia Medicaid’s routes to Wegovy, from DMAS’s drug list and service authorization forms, read November 1, 2026.

Virginia prices

What does semaglutide cost in Virginia without coverage?

Without approval, Virginians pay cash: NovoCare Pharmacy charges $199 a month for a new patient’s first two Wegovy pen fills (through December 31, 2026), then $349, and $149 to $299 for the pill. Compounded semaglutide, not FDA-approved, costs $119 to $299 a month online in our price index, and $119 at NexLife on the 12-month plan or $139 month to month.

Coverage rules from DMAS and DHRM, read November 1, 2026; NovoCare’s cash prices checked November 1, 2026; compounded prices from our GLP-1 price index (November 1, 2026). NovoCare’s prices cover the medication only.
RoutePrice a monthDetails
Virginia Medicaidweight lossCovered if approvedInjectable Wegovy first; BMI above 40, or above 37 with a risk factor
State employee planssince July 1, 2026Covered if approvedPrior authorization; a BMI of 35 or more for new requests
Wegovy pillNovoCare Pharmacy, cash price$149 to $2991.5 mg: $149; 4 mg: $199; 9 or 25 mg: $299
Wegovy penNovoCare Pharmacy, cash price$349 0.25 to 2.4 mgNew patients pay $199 a month for their first 2 monthly fills, at 0.25 or 0.5 mg, through December 31, 2026. Wegovy HD 7.2 mg: $399 a month
Compounded semaglutide17 programs in our price index$119 to $299$199 at the median; not FDA-approved
NexLifecompounded, every dose$119 on the 12-month plan, $125 on 6 months, $132 on 3 months, $139 month to monthNo membership fee; HSA and FSA cards accepted

Swipe the table sideways to see every column.

Coverage rules from DMAS and DHRM, read November 1, 2026; NovoCare’s cash prices checked November 1, 2026; compounded prices from our GLP-1 price index (November 1, 2026). NovoCare’s prices cover the medication only.

Not prescribed? NexLife doesn’t charge for medication. HSA and FSA cards work, and NexLife provides a letter of medical necessity if your plan asks for one; Affirm, Klarna and Afterpay can spread the cost.

Compare

How do online programs price semaglutide for Virginians?

Month to month, PreventiveMD lists $119 at every dose (checked November 1, 2026), and Ondra Health ($149) and Rx.com ($175) keep one price too. Mochi Health starts at $139, its membership included, and rises with the dose (checked November 1, 2026).

Listed A to Z. Prices from each company’s own site, checked November 1, 2026. NexLife publishes this guide and doesn’t rank itself. Wegovy is FDA-approved; compounded semaglutide isn’t.
ProgramMonth to month, all inHow the price movesWorth knowing
Mochi HealthCompounded$139 lowest doseRises with the doseIncludes its $79 monthly membership
NexLifeCompounded · publisher of this guide$139Same at every dose; $119 a month on the 12-month planNo membership; provider care, a coaching call and free shipping included
NoomCompounded$279$129 for the first 4-week supplyBilled $837 every 12 weeks
Ondra HealthCompounded$149Same at every dose$96 a month on its 12-month plan
PreventiveMDCompounded$119Same at every dosePrice checked November 1, 2026
Remedy MedsCompounded$299 every 4 weeks$179 for the first 4 weeksA 4-week supply at a time
Rx.comCompounded$175Same at every dose$99 a month on its 12-month plan; no automatic renewals
NovoCare PharmacyBrand-name WegovyPill $149 to $299; pen $349The pill’s price rises with the doseFDA-approved; medication only

Swipe the table sideways to see every column.

Listed A to Z. Prices from each company’s own site, checked November 1, 2026. NexLife publishes this guide and doesn’t rank itself. Wegovy is FDA-approved; compounded semaglutide isn’t.

Ten programs get full, sourced reviews in our guide to the best semaglutide providers online.

Vial math

How many units is your semaglutide dose?

It depends on your vial’s strength. Here are the Wegovy label’s dose steps at two example strengths.

Semaglutide dose steps from the Wegovy label, with the volume and units on a U-100 syringe at two example strengths, 2.5 mg/mL and 5 mg/mL
WeeksWeekly doseAt 2.5 mg/mLAt 5 mg/mL
1 to 40.25 mg0.1 mL (10 units)0.05 mL (5 units)
5 to 80.5 mg0.2 mL (20 units)0.1 mL (10 units)
9 to 121 mg0.4 mL (40 units)0.2 mL (20 units)
13 to 161.7 mg0.68 mL (68 units)0.34 mL (34 units)
17 onward2.4 mg0.96 mL (96 units)0.48 mL (48 units)

The math: mL = dose ÷ strength (mg per mL); units = mL × 100. At 2.5 mg/mL, 1 mg is 1 ÷ 2.5 = 0.4 mL, or 40 units. At 5 mg/mL, the same 1 mg is 0.2 mL, or 20 units.

Both strengths are examples only. The same dose is a different number of units at a different strength, so read the strength on your own vial’s label. Your prescription sets your dose and schedule, which may differ from these label steps. Every step: the semaglutide dosage chart.

Two medications.
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $139/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $119/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan; $139/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

The NexLife Price Match Guarantee†

Keep your price.
Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

Semaglutide in Virginia: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

Does Virginia Medicaid cover Wegovy?

Yes, but only with service authorization. Wegovy injections are covered from age 12 when BMI is over 40, or over 37 with abnormal cholesterol, high blood pressure or type 2 diabetes, and a non-GLP-1 weight-loss drug has failed. Wegovy tablets also need a medical reason injections won't work, or two failed injectables.

Do Virginia state employee plans cover Wegovy?

They cover weight-loss GLP-1s only with prior authorization and, since July 1, 2026, a BMI of 35 or higher for new approvals. COVA Care, HealthAware and HDHP switched to a new drug list on July 1, 2026, so check Wegovy's status before you fill.

Is compounded semaglutide legal in Virginia?

It can be, within limits. Virginia lets pharmacists compound for a specific patient with a valid prescription under USP standards, but bars regular compounding of copies of commercially available drugs unless the prescriber orders a change for that patient. Compounded semaglutide is not FDA-approved; FDA declared the semaglutide shortage resolved February 21, 2025.

Do I need a Virginia-licensed prescriber for semaglutide?

Yes. A prescriber must be licensed in Virginia to treat you while you're in Virginia, and state law requires an active Virginia license to start care online. Virginia's official compact list doesn't include the Interstate Medical Licensure Compact. You can verify any prescriber's license on the state's License Lookup.

Can an out-of-state pharmacy mail compounded semaglutide to Virginia?

Yes, if it is registered with the Virginia Board of Pharmacy as a nonresident pharmacy. It must name a pharmacist-in-charge licensed in Virginia, send a current inspection report showing USP compliance, and notify the Board before shipping sterile compounded drugs. Unregistered out-of-state pharmacies may not ship compounded sterile products into Virginia.

How do I keep semaglutide cold in Virginia heat?

Expect long hot stretches. In summer 2026, Norfolk reached 86°F or more on 68 days and Lynchburg on 72, and Roanoke hit 100°F three days in a row in early July. Don't leave packages on a porch or in a car, and store your medicine the way your pharmacy's label says.

How much does compounded semaglutide cost in Virginia?

Online, compounded semaglutide costs $119 to $299 a month, all in, with a median of $199 (GLP-1 price index, checked November 1, 2026). Brand Wegovy pens cost $199 for each of a new patient's first two fills at NovoCare Pharmacy, then $349 a month ($399 at 7.2 mg). The Wegovy pill runs $149 to $299.

Does Medicare cover Wegovy in Virginia?

Yes, for eligible Part D enrollees through the Medicare GLP-1 Bridge: $50 a month with prior authorization, July 1, 2026 to December 31, 2027. It covers Wegovy injections and tablets. You need a qualifying BMI and must not have type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease, which your plan may already cover.

Where can I get semaglutide in Virginia Beach or Norfolk?

You need a prescriber licensed in Virginia, whether you're in Virginia Beach, Norfolk or Chesapeake, and you can get care online. The prescription must be filled by a pharmacy licensed or registered by the Virginia Board of Pharmacy. Compounded semaglutide is made for you by prescription. Check licenses on Virginia's License Lookup.

Does The Local Choice cover Wegovy for school employees?

Not in its Key Advantage plans. The Key Advantage handbook, effective July 1, 2026 (October 1, 2026 for certain school groups), lists drugs for weight loss as not covered. Bariatric surgery may be covered for morbid obesity after a 6-month weight program. Ask your benefits office which plan your division uses.

IN YOUR STATE

Not in Virginia? Pick your state

Tap your state on the map for its guide.

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginia: you’re hereWashingtonWest VirginiaWisconsinWyoming
  • Available through NexLife
  • You’re here
  • Selected

Virginia (you’re here): compounded semaglutide is available through NexLife, $119/mo on the 12-month plan or $139 month to month, the same at every dose.

Check my eligibility

Compounded medications aren’t FDA-approved. A licensed provider prescribes one only when it offers a significant difference for you.

Rules, coverage and prices by state →

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. NexLife is offered only in states where our affiliated providers are licensed.

Who wrote and checked this page

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Virginia’s rules and Wegovy’s prices read November 1, 2026; program prices November 1, 2026.

  • How we checked. We read Virginia’s rules at the source on November 1, 2026: the Medicaid drug list and service authorization forms, the state employee plans’ Spring 2026 benefits guide and August 12 update, and the Code of Virginia. Novo Nordisk’s own site gave Wegovy’s cash prices the same day, and CDC’s 2025 maps gave the obesity figures. Program prices come from each company’s site (November 1, 2026), and the compounded range from our GLP-1 price index (November 1, 2026).
  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.

Paying less elsewhere? We match it.†

One semaglutide price, from the first dose up.

Compounded semaglutide through NexLife costs $119 a month on the 12-month plan, or $139 month to month, all in. A licensed provider decides if it’s right for you, and if you’re not prescribed, you pay nothing for medication.

4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    A licensed provider reviews your health history and decides whether treatment is right for you, following your state’s rules. You’re prescribed only if it is.

  3. 3
    We ship it, then stay with you

    Free expedited shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. Virginia DMAS: Preferred Drug List / Common Core Formulary, effective October 1, 2026. Checked November 1, 2026.
  2. Virginia DMAS: Service Authorization Form, Weight-Loss Management (effective October 20, 2026). Checked November 1, 2026.
  3. Virginia DMAS: Service Authorization Form, GLP-1 Receptor Agonists for Cardiovascular Risk Reduction in Members with Obesity or Overweight (effective May 1, 2026). Checked November 1, 2026.
  4. Virginia DMAS: Service Authorization Form, GLP-1 Receptor Agonists for MASH (revised October 16, 2025). Checked November 1, 2026.
  5. Virginia DHRM: Spotlight on Your Benefits, Spring 2026 (changes starting July 1, 2026). Checked November 1, 2026.
  6. Virginia DHRM, Office of State Health Benefits: Health Benefits E-News, August 12, 2026 (updated weight-loss GLP-1 prior authorization criteria). Checked November 1, 2026.
  7. Code of Virginia § 54.1-3434.1: nonresident pharmacies to register with the Board. Checked November 1, 2026.
  8. Code of Virginia § 54.1-3410.2: compounding, including the sterile compounding notice (subsection K). Checked November 1, 2026.
  9. Code of Virginia § 54.1-3303: prescriptions and the bona fide practitioner-patient relationship. Checked November 1, 2026.
  10. Virginia Board of Pharmacy (Department of Health Professions). Checked November 1, 2026.
  11. Virginia Department of Health Professions: License Lookup. Checked November 1, 2026.
  12. CDC: Adult Obesity Prevalence Maps, 2025 data (updated September 24, 2026). Checked November 1, 2026.
  13. CDC: 2025 adult obesity prevalence by age group, state maps. Checked November 1, 2026.
  14. Novo Nordisk: Wegovy self-pay prices at NovoCare Pharmacy. Checked November 1, 2026.
  15. GLP-1 price index (NexLife). Checked November 1, 2026.
  16. PreventiveMD: semaglutide protocol and price. Checked November 1, 2026.
  17. Mochi Health: FAQs, membership and medication prices. Checked November 1, 2026.
  18. Noom: GLP-1Rx compounded semaglutide price. Checked November 1, 2026.
  19. Ondra Health: plans and prices. Checked November 1, 2026.
  20. Remedy Meds: compounded semaglutide prices. Checked November 1, 2026.
  21. Rx.com: compounded semaglutide prices. Checked November 1, 2026.
  22. NexLife: semaglutide plans and prices. Checked November 1, 2026.
  23. Virginia Department of Medical Assistance Services (DMAS form, copy hosted by UnitedHealthcare Community Plan of Virginia). Commonwealth of Virginia DMAS Service Authorization (SA) Form: Weight-Loss Management. Revised 04/16/2026.
  24. Virginia Administrative Code (DMAS regulation). 12VAC30-50-210. Prescribed drugs. Last amended eff. April 4, 2021.
  25. Virginia Department of Medical Assistance Services. Virginia Medicaid Preferred Drug List / Common Core Formulary and New Drug Utilization Review Board Approved Drug Service Authorizations Effective July 1, 2024 (bulletin). Last updated 2024-09-09; PDL change effective 2024-08-01.
  26. Virginia Department of Medical Assistance Services. Medicaid Expenditures for Diabetic and Weight Loss Drugs (report to the General Assembly, RD208). 2024-03-21.
  27. Virginia Department of Human Resource Management (State Health Benefits Program). COVA Care Member Handbook, July 2026 (A10863). July 2026.
  28. The Local Choice, Virginia Department of Human Resource Management. The Local Choice - Home.
  29. The Local Choice Health Benefits Program, Virginia Department of Human Resource Management. Key Advantage Member Handbook (A10864).
  30. Aetna (posted by University of Virginia Human Resources). October formulary updates: Advanced Control Formulary effective October 1, 2026. 7/2026; changes effective 2026-10-01.
  31. University of Virginia Human Resources. UVA Health Plan's Prescription Drug Program (2026 benefits). Last updated 2026-09-19.
  32. Code of Virginia (Virginia General Assembly, LIS). § 38.2-3418.13. Coverage for the treatment of morbid obesity. Code as of 11/2/2026; last amended 2014, c. 814.
  33. Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge, overview and FAQs.
  34. TRICARE. TRICARE coverage of weight loss medications: what to know (Aug. 5, 2025).
  35. Code of Virginia (Virginia General Assembly, LIS). § 38.2-3561. Standard external review. Code as of 11/2/2026.
  36. Code of Virginia (Virginia General Assembly, LIS). § 38.2-3562. Expedited external review. Code as of 11/2/2026.
  37. Code of Virginia (Virginia General Assembly, LIS). § 38.2-3569. Funding of external review. Code as of 11/2/2026; 2011, c. 788.
  38. Code of Virginia (Virginia General Assembly, LIS). § 38.2-3557. Scope of chapter (Health Carrier Internal Appeal Process and External Review). Code as of 11/2/2026; 2011, c. 788.
  39. Code of Virginia (Virginia General Assembly, LIS). § 54.1-3303. Prescriptions to be issued and drugs to be dispensed for medical or therapeutic purposes only. Code as of 11/2/2026.
  40. Virginia Board of Medicine. Guidance Document 85-12: Telemedicine. Revised 2021-06-24; effective 2021-08-19.
  41. Virginia Department of Health Professions (Boards of Medicine, Nursing and Pharmacy). Guidance Document 76-1: Regulatory Considerations for IV Hydration Clinics and Med Spas in Virginia. Effective 2026-10-08.
  42. Code of Virginia (Virginia General Assembly, LIS). Virginia Compacts (list of interstate compacts Virginia has joined). Page dated 11/2/2026.
  43. Code of Virginia (Virginia General Assembly, LIS). § 54.1-2957. Licensure and practice of advanced practice registered nurses. Code as of 11/2/2026.
  44. Code of Virginia (Virginia General Assembly, LIS). § 54.1-2952.1. Prescription of certain controlled substances and devices by licensed physician assistants (version in effect until Acts 2026, c. 418 takes effect). Code as of 11/2/2026.
  45. Virginia General Assembly (LIS). Acts of Assembly 2026, Chapter 418 (HB 746): physician assistants; authorization to practice without a practice agreement. 2026 Regular Session.
  46. Virginia Board of Pharmacy. Guidance Document 110-36: Compliance with USP Standards for Compounding. Revised 2024-03-28; effective 2024-06-06.
  47. Virginia Board of Pharmacy. Guidance Document 110-38: Requirement for Non-resident Pharmacies and Outsourcing Facilities to Submit Current Inspection Report.
  48. Virginia Board of Pharmacy. Guidance Documents (list).
  49. U.S. Court of Appeals for the Fifth Circuit. Outsourcing Facilities Association v. FDA, No. 25-10758 (Aug. 27, 2026).
  50. U.S. Food and Drug Administration. Compounding and the FDA: questions and answers.
  51. Novo Nordisk. Wegovy (semaglutide) prescribing information.
  52. NOAA Regional Climate Centers (ACIS). Daily maximum temperatures, June 1 to September 30, 2026.
  53. Code of Virginia (Virginia General Assembly, LIS). § 54.1-3411. When prescriptions may be refilled. Code as of 11/2/2026; last amended 2023, c. 341.
  54. Code of Virginia (Virginia General Assembly, LIS). § 54.1-3455. Schedule VI. Code as of 11/1/2026.
  55. Centers for Medicare & Medicaid Services (Medicare.gov). Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month (CMS Product No. 12234). June 2026.
  56. U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. Update of 2/21/2025 (page updated through 4/1/2026).
  57. U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.